We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Urology

Journal Scan / Research · May 21, 2022

Association of Neoadjuvant Chemotherapy Use With the Risk of Postoperative Complications Following Radical Cystectomy

World Journal of Urology


Additional Info

World Journal of Urology
Neoadjuvant chemotherapy does not increase peri-operative morbidity following radical cystectomy
World J Urol 2022 Apr 30;[EPub Ahead of Print], A Arora, AS Zugail, F Pugliesi, X Cathelineau, P Macek, Y Barbé, RJ Karnes, M Ahmed, E Di Trapani, F Soria, M Alvarez-Maestro, F Montorsi, A Briganti, A Necchi, B Pradere, D D'Andrea, W Krajewski, M Roumiguié, AS Bajeot, R Hurle, R Contieri, R Carando, JY Teoh, M Roupret, D Benamran, G Ploussard, MC Mir, R Sanchez-Salas, M Moschini

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading